CSF Aβ1–42, but not p-Tau181, differentiates aMCI from SCI

Liara Rizzi,Marcelle Maria Portal,Carlos Eduardo Alves Batista,Luciane Missiaggia,Matheus Roriz-Cruz

Brain Research（2018）

引用 7|浏览21

暂无评分

摘要

•CSF levels of biomarkers were compared in individuals with aMCI and SCI.•Individuals with Aβ1–42 < 823 pg/mL were 6 times more likely to be diagnosed with aMCI.•CSF Aβ1–42, but not p-Tau181, level was significantly associated with aMCI.

查看译文

关键词

Alzheimer,Amyloid,CSF Biomarkers,MCI,Tau

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要